For Cmax, the model-predicted ratios in patients with CP-A, CP-B, and CP-C cirrhosis, relative to healthy volunteers, were 1.16, 1.59, and 1.87, respectively (Table 3). This evidence concerns the gene CPA1 and Cirrhosis.